Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography
British Journal of Cancer2016Vol. 114(11), pp. 1269–1276
Citations Over TimeTop 10% of 2016 papers
Abstract
Adjustment for nonadherence increased the size of the mortality benefit and risk of overdiagnosis by up to 50%. These estimates are more appropriate when developing quantitative information to support individual decisions about attending screening mammography.
Related Papers
- → Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program(2012)244 cited
- → Digital mammography screening: Weighing reduced mortality against increased overdiagnosis(2011)55 cited
- → Breast Cancer Screening Frequency and Overdiagnosis(2017)1 cited
- → [Discussion of breast cancer screening model in China].(2016)7 cited
- → Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk(2013)2 cited